Sp438
MICROBIAL BILE ACID MODULATION AND IT'S ROLE IN METABOLIC HOMESTASIS
Date
May 19, 2024
Tracks
Related Products
DURABILITY OF THE CLINICAL RESPONSE TO SER-109, AN INVESTIGATIONAL ORAL MICROBIOME THERAPEUTIC, IN A PHASE 3 OPEN-LABEL TRIAL (ECOSPOR IV) IN PATIENTS WITH RECURRENT <i>CLOSTRIDIOIDES DIFFICILE</i> INFECTION
BACKGROUND: Recurrent _Clostridioides difficile _infection (rCDI) is a debilitating disease associated with significant healthcare burden and low quality of life. The greatest risk factor for rCDI is a history of recurrence, although older age (≥65 years) and comorbidities also increase risk…
EMPLOYING AUTOMATED MACHINE LEARNING TO PREDICT BOWEL SURGERY RISK IN IBD PATIENTS POST-CDI: A COMPREHENSIVE ANALYSIS
BACKGROUND: Machine learning holds great potential in enhancing patient care by early prediction of clinical outcomes, yet the challenge lies in determining the most suitable model from a pool of constantly increasing options…